| scholarly article | Q13442814 |
| P50 | author | Zbigniew Zaslona | Q57167919 |
| Marc Peters-Golden | Q82192734 | ||
| P2093 | author name string | Katsuhide Okunishi | |
| Angela J DeGraaf | |||
| P2860 | cites work | mTOR: from growth signal integration to cancer, diabetes and ageing | Q24633662 |
| Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels | Q24806806 | ||
| Regulation of immune responses by prostaglandin E2 | Q26849305 | ||
| COX-2 expression and cell cycle progression in human fibroblasts | Q28184985 | ||
| Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. | Q53594811 | ||
| Differential regulation by leukotrienes and calcium of Fc gamma receptor-induced phagocytosis and Syk activation in dendritic cells versus macrophages. | Q53629779 | ||
| The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts | Q69542548 | ||
| Intracellular degradation of newly synthesized collagen | Q71606664 | ||
| Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase | Q28574027 | ||
| Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes | Q30472934 | ||
| Fibrotic myofibroblasts manifest genome-wide derangements of translational control | Q33369846 | ||
| Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. | Q33613235 | ||
| Building collagen molecules, fibrils, and suprafibrillar structures. | Q34133305 | ||
| Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. | Q34211740 | ||
| Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators | Q34525796 | ||
| TGFβ- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR) | Q35041204 | ||
| In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist | Q35636109 | ||
| Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases | Q35649473 | ||
| Prostaglandin E2 promotes intestinal tumor growth via DNA methylation | Q35742739 | ||
| Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. | Q35907174 | ||
| A unifying model for mTORC1-mediated regulation of mRNA translation. | Q35945036 | ||
| Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity | Q35973067 | ||
| Prostanoid EP₁ receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB. | Q36158964 | ||
| Prostaglandin E₂ increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression | Q36183709 | ||
| Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts | Q36279948 | ||
| Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. | Q36470315 | ||
| The translational landscape of mTOR signalling steers cancer initiation and metastasis | Q36873513 | ||
| The macrophage: past, present and future | Q36986722 | ||
| Putting on the brakes: cyclic AMP as a multipronged controller of macrophage function | Q37521452 | ||
| Ribosomal protein S6 kinase from TOP mRNAs to cell size | Q37726439 | ||
| cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. | Q38657890 | ||
| Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D. | Q39656356 | ||
| Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass | Q39756963 | ||
| Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades | Q39804717 | ||
| Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells | Q39859443 | ||
| Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1. | Q39990887 | ||
| Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency | Q40233725 | ||
| Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent? | Q40242728 | ||
| cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. | Q40568376 | ||
| Resistance to Fas-mediated apoptosis in human lung fibroblast | Q40706480 | ||
| Prostaglandin E(2) inhibits fibroblast chemotaxis | Q40775240 | ||
| The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice | Q40794888 | ||
| Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. | Q41138646 | ||
| Collagen: scaffold for repair or execution | Q41418665 | ||
| Discordant regulation of human type I collagen genes by prostaglandin E2 | Q41627947 | ||
| SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway | Q42831977 | ||
| Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase | Q42998099 | ||
| Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. | Q44435135 | ||
| Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys | Q44869335 | ||
| Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process | Q50233076 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostaglandin E2 | Q416554 |
| P304 | page(s) | 56-66 | |
| P577 | publication date | 2013-09-26 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Inhibition of protein translation as a novel mechanism for prostaglandin E2 regulation of cell functions | |
| P478 | volume | 28 |
| Q92069090 | Antibiotic pretreatment alleviates liver transplant damage in mice and humans |
| Q50879214 | Distinct PKA regulatory subunits mediate PGE2 inhibition of TGFβ-1-stimulated collagen I translation and myofibroblast differentiation. |
| Q53528564 | Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal Cancer. |
| Q38944697 | Nutritional status-dependent endocannabinoid signalling regulates the integration of rat visceral information |
| Q34103733 | Prostaglandin E2 reduces Toll-like receptor 4 expression in alveolar macrophages by inhibition of translation |
| Q36549053 | Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation |
| Q56978001 | Special Delivery: A New Package for an Old Anti-Fibrotic Mediator |
Search more.